Latuda and Coma - a phase IV clinical study of FDA data

Summary:

Coma is reported as a side effect among people who take Latuda (lurasidone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Schizoaffective disorder.

The phase IV clinical study analyzes which people have Coma when taking Latuda. It is created by eHealthMe based on reports of 20,677 people who have side effects when taking Latuda from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,541 Latuda users. Check the latest studies of Latuda.

What is Coma?

Coma (state of unconsciousness lasting more than six hours) is found to be associated with 2,894 drugs and 3,168 conditions by eHealthMe. Check the latest studies of Coma.

On Oct, 18, 2025

20,677 people reported to have side effects when taking Latuda.
Among them, 24 people (0.12%) have Coma.

Among these 24 people:

How long have people been on Latuda when they have Coma? *

What is the gender of people who have Coma when taking Latuda? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Coma when taking Latuda? *

What are other drugs people take besides Latuda? *

What are other side effects people have besides Coma? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 25.00%
Haematemesis (vomiting of blood): 4 people, 16.67%
Agitation (state of anxiety or nervous excitement): 4 people, 16.67%
Weight Increased: 3 people, 12.50%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 12.50%
Fatigue (feeling of tiredness): 3 people, 12.50%
Fall: 3 people, 12.50%
Facial Bones Fracture (bone fracture of face): 3 people, 12.50%
Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 12.50%
Joint Dislocation (a joint position is changed from normal position): 3 people, 12.50%

What are the existing conditions these people have? *

Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 12.50%
Stress And Anxiety: 2 people, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 8.33%
Irritability: 2 people, 8.33%
Psychotic Disorder: 1 person, 4.17%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.17%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 4.17%
Diabetes: 1 person, 4.17%
Dementia (madness): 1 person, 4.17%
Birth Control: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and have Coma?

- Check whether Coma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latuda:

Latuda (21,541 reports)

Coma treatments and more:

Coma (57,420 reports)

Browse all side effects of Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coma:

Coma (2,894 drugs)

Browse all the conditions that are associated with Coma:

Coma (3,168 conditions)

Drugs similar to Latuda and Coma :

Related publications that referenced our studies

Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .
Reddy, B., Das, S., & Ali, M. , "A Case of Hypersexuality Probably Associated With Lurasidone", Journal of clinical psychopharmacology, 2018 Jan .
Sood S, "Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone", Clinical Psychopharmacology and Neuroscience, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on lurasidone hydrochloride (the active ingredients of Latuda) and Latuda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.